Geron Corporation
NASDAQ:GERNBiotechnology
Healthcare
$0.91 +4.07%
+$0.05 today
- Market cap
- $588.19M
- Beta
- 0.60
- P/E (TTM)
- -12.3
- EPS (TTM)
- -$0.10
52W Low $1.04High $2.01
Volume 19.64M
Average 16.28M
Balance Sheet
Inspect the capital base behind the business.
Assets
$570.54M
FY 2025 · Annual
-3.9% YoYLiabilities
$344.67M
FY 2025 · Annual
+10.0% YoYEquity
$225.87M
FY 2025 · Annual
-19.4% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 34.87M | 56.85M | 70.02M | 79.02M | 79.44M |
| Short-term Investments | 148.85M | 115.9M | 263.68M | 327.55M | 280.36M |
| Net Receivables | 1.76M | 3.14M | 1.66M | 38.8M | 39.23M |
| Inventory | 0 | 0 | 0 | 38.71M | 0 |
| Other Current Assets | 364K | 4.36M | 5.99M | 6.91M | 121.25M |
| Total Current Assets | 187.21M | 180.25M | 341.35M | 490.99M | 520.27M |
| Property, Plant & Equipment (Net) | 5.38M | 4.94M | 4.73M | 4.19M | 884K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 28.65M | 0 | 43.3M | 94.52M | 41.29M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 4.8M | 5.39M | 4.7M | 4.08M | 8.1M |
| Total Non-current Assets | 38.83M | 10.33M | 52.73M | 102.79M | 50.27M |
| Total Assets | 226.03M | 190.58M | 394.08M | 593.78M | 570.54M |
| Account Payables | 6.69M | 10.19M | 6.16M | 8.6M | 11.26M |
| Short-term Debt | 0 | 20.95M | 46.89M | 0 | 18.45M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 8.1M | 11.53M | 13.76M | 43.18M | 80.84M |
| Total Current Liabilities | 45.52M | 76.69M | 108.07M | 88.3M | 111.54M |
| Long-term Debt | 49.83M | 30.21M | 35.05M | 118.48M | 231.68M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 104.42M | 0 |
| Total Non-current Liabilities | 54.1M | 33.88M | 38.06M | 225.16M | 233.13M |
| Total Liabilities | 99.62M | 110.58M | 146.13M | 313.46M | 344.67M |
| Common Stock | 324K | 390K | 545K | 606K | 640K |
| Retained Earnings | (1.27B) | (1.41B) | (1.6B) | (1.77B) | (1.86B) |
| Accumulated OCI | (173K) | (219K) | 185K | 261K | 269K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 126.42M | 80M | 247.95M | 280.32M | 225.87M |
| Total Debt | 55M | 55.75M | 85.9M | 121.72M | 251.57M |
| Net Debt | 20.13M | (1.09M) | 15.88M | 42.7M | 172.13M |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $70.8M |
| Short-term Investments | $243.5M |
| Receivables | $44.1M |
| Other Current | $140.2M |
| Total Current Assets | $498.5M |
| PP&E (Net) | $1.0M |
| Long-term Investments | $26.7M |
| Other Non-current | $7.9M |
| Total Non-current Assets | $35.6M |
| Total Assets | $534.1M |
Analysis
Selected assets total $534.1M for Latest. The largest visible component is Short-term Investments at $243.5M, about 45.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G | SC 13G filing | Nov 10, 2026 | |
| 8-K | Current report | Nov 4, 2026 | |
| 10-Q | Quarterly report | Nov 4, 2026 | |
| 8-K | Current report | Oct 28, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 1, 2026 |
How much cash does GERN have?
Geron Corporation (GERN) reported $79.44M in cash and equivalents in fiscal 2025.
How much debt does GERN carry?
Geron Corporation (GERN) reported $251.57M of total debt, with net debt of $172.13M.
Continue the stock analysis
Jump to another research area for this company.